Preparation and characterisation of inclusion complexes of meloxicam and α-cyclodextrin and β-cyclodextrin

Farmacia

Volumn 58, Issue 5, 2010, Pages 583-593

  Miclea, Lenuţa Maria ^a   Vlaia, Lavinia ^a   Vlaia, V ^a   Hǎdǎrugǎ, Daniel I ^b   Mircioiu, Constantin ^c  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b POLITEHNICA UNIVERSITY OF TIMISOARA   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

cyclodextrin; cyclodextrin; Inclusion complexes; Meloxicam

Indexed keywords

ALCOHOL; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; MELOXICAM; WATER;

ARTICLE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ANALYSIS; DRUG SOLUBILITY; DRUG SYNTHESIS; MORPHOLOGY; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; THERMAL ANALYSIS; THERMOGRAVIMETRY;

EID: 77958595062     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Szejtli J., Past, present, and future of cyclodextrin research, Pure Appl. Chem., 2004, 76 (10), 1825-1845.
2. Kim L. L., Large Cyclodextrins, J. Incl. Phenom. Macrocycl. Chem., 2002, 43, 1-13.
3. Salustio P.J., Feio G., Figueirinhas J.L., Pinto J.F., Marques C. H. M., The influence of the preparation methods on the inclusion of model drugs in a β-Cyclodextrin cavity, Eur. J. Pharm. Biopharm., 2009, 71, 377-386.
4. Kim H., Lee I., A novel drug delivery system design for meloxicam, JPharm Pharmaceut Sci, 2007, 10 (3), 288-298.
5. Obaidat A. A., Khanfar R. A., Khawam M. N., The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling, J. Incl. Phenom. Macrocycl. Chem., 2009, 63, 273-279.
6. Baboota S., Agarwal S.P., Preparation and characterization of meloxicam hydroxy propyl β- cyclodextrin of inclusion complex, J. Incl. Phenom. Macrocycl. Chem., 2005, 51, 219-224. (Pubitemid 40897904)
7. Aigner Z., Kezsmarki A., Kata M., Novak C., Istvan E., Investigation of tenoxicam and γ- cyclodextrin binary and ternary complexes, J. Incl. Phenom. Macrocycl. Chem., 2002, 42, 227-233. (Pubitemid 38075795)
8. Hǎdǎrugǎ I.D., Hǎdǎrugǎ N.G., Miclea L.-M., Vlaia L. Mircioiu C. Bioactive compounds (antiinflammatory and hepatoprotective xenobiotic)/cyclodextrins nanoparticles: comparative study, J. Agroalim. Proc. Technol., 2009, XV, 4, 478-483.
9. Nicolescu C., Aramǎ C., Monciu C.-M., Preparation and characterization of inclusion complexes between repaglinide and β-cyclodextrin, 2-hydroxypropyl-β- cyclodextrin and randomly methylated β-cyclodextrin, Farmacia, 2010, 58 (1), 78-88.
10. Liu L., Zhu S., Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β- cyclodextrin, J. Pharm. Biomed. Anal., 2006, 40, 122-127. (Pubitemid 43061226)
11. Trandafirescu C., Gyéresi Á., Kata M., Aigner Z., Szabadai Z., Study of albendazolehydroxypropyl- β-cyclodextrin binary systems, Farmacia, 2007, LV, 5, 580-589.
12. Trandafirescu C., Gyeresi Á., Kata M., Aigner Z., Szabadai Z., Preparation and characterisation of albendazole - random methyl-β- cyclodextrin binary systems, Farmacia, 2007, LV, 1, 98-107.
13. Doijad C.R., Kanakal M.M., Manvi F.V., Effect of processing variables on dissolution and solubility of piroxicam: Hydroxypropyl β-cyclodextrin inclusion complex, Indian J. Pharm. Sci., 2007, 69 (2), 323-326.
14. Tereknova V. I., Volkova V. Tatiana, Perlovich L. German, Experimental analysis of complex formation of niflumic acid with β-cyclodextrins, J. Incl. Phenom. Macrocycl. Chem., 2006, 55, 335-340.
15. Jansook P., Loftsson T., γ-CD/HPγCD:Synergistic solubilization, Int. J. Pharm., 2008, 363, 217-219.